TCL Archive Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down May 31, 2013
TCL Archive “Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says September 25, 1998
TCL Archive Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results April 4, 1986
TCL Archive Bristol-Myers Runs Afoul Of FDA In Attempt To Distribute Chapters of Oncology Textbook June 19, 1992
